Intensity Modulated Radiation Therapy for Head and Neck Cancer

NCT00188877 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Neoplasms

Interventions

PROCEDURE: intensity modulated radiation therapy
DRUG: cisplatinium and fluorouracil - standard treatment

Sponsor

University Health Network, Toronto

Collaborators

[object Object]